Projects per year
Fingerprint
Dive into the research topics where Gil Awada is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
- 1 Finished
Research output
-
A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab
Awada, G., Jansen, Y., Schwarze, J. K., Tijtgat, J., Hellinckx, L., Gondry, O., Vermeulen, S., Warren, S., Schats, K., van Dam, P-J., Kockx, M., Keyaerts, M., Everaert, H., Seremet, T., Rogiers, A. & Neyns, B., 2 Jan 2021, In : Cancers. 13, 2, p. 1-18 18 p., 168.Research output: Contribution to journal › Article
-
Choriocapillaris Assessment In Patients Under Mek-Inhibitor Therapy For Cutaneous Melanoma: An Optical Coherence Tomography Angiography Study
Fasolino, G., Awada, G., Koulalis, J. S., Neyns, B., Van Elderen, P., Kuijpers, R. W., Nelis, P. & Ten Tusscher, M., 2021, In : Seminars in Ophthalmology. p. 1-7 7 p.Research output: Contribution to journal › Article
-
Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma: a new emerging treatment?
Sol, B., de Filette, J. M. K., Awada, G., Raeymaeckers, S., Aspeslagh, S., Andreescu, C. E., Neyns, B. & Velkeniers, B., Jan 2021, In : European Journal of Endocrinology. 184, 1, p. K1-K5 5 p.Research output: Contribution to journal › Article
2 Citations (Scopus) -
Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse
Jansen, Y. J. L., Willekens, I., Seremet, T., Awada, G., Schwarze, J. K., De Mey, J., Brussaard, C. & Neyns, B., 25 Jan 2021, In : Cancers. 13, 3, p. 1-13 13 p., 442.Research output: Contribution to journal › Article
-
65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma
Schwarze, J. K., Bertels, C., Awada, G., Tijtgat, J., Tuyaerts, S., Cras, L., Vaeyens, F., Vanbinst, A-M., Everaert, H., Michotte, A., Caljon, B., Olsen, C., Janssen, T., Van Dooren, S., Forsyth, R., Duerinck, J. & Neyns, B., Dec 2020, In : Annals of Oncology. 31, S7, p. S1443-S1443Research output: Contribution to journal › Meeting abstract (Journal)
Prizes
-
Best Poster Award
Gil Awada (Recipient), Ibrahim Özdemir (Recipient), Julia Katharina Schwarze (Recipient), Emma Daeninck (Recipient), Odrade Gondry (Recipient), Yanina Jansen (Recipient), Teofila Seremet (Recipient), Marleen Keyaerts (Recipient), Hendrik Everaert (Recipient) & Bart Neyns (Recipient), 15 Dec 2018
Prize: Prize (including medals and awards)
Activities
-
Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab
Gil Awada (Speaker), Ibrahim Özdemir (Contributor), Julia Katharina Schwarze (Contributor), Emma Daeninck (Contributor), Odrade Gondry (Contributor), Yanina Jansen (Contributor), Teofila Seremet (Contributor), Marleen Keyaerts (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor)14 Dec 2018Activity: Talk or presentation › Talk or presentation at a conference
-
Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab
Odrade Gondry (Speaker), Ibrahim Özdemir (Contributor), Yanina Jansen (Contributor), Gil Awada (Contributor), Julia Katharina Schwarze (Contributor), Teofila Seremet (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor), Marleen Keyaerts (Contributor)19 Oct 2018Activity: Talk or presentation › Talk or presentation at a workshop/seminar